000

HYUNDAI PHARM

No trades
See on Supercharts
Market capitalization
‪100.78 B‬KRW
‪6.12 B‬KRW
‪180.76 B‬KRW
‪15.71 M‬
Beta (1Y)
−0.17
Employees (FY)
385
Change (1Y)
+7 +1.85%
Revenue / Employee (1Y)
‪359.65 K‬KRW
Net income / Employee (1Y)
‪12.18 K‬KRW

About HYUNDAI PHARM


CEO
Sang-Joon Lee
Headquarters
Cheonan
Founded
1965
ISIN
KR7004310009
FIGI
BBG000BDMGN3
Hyundai Pharmaceutical Co., Ltd. engages in the manufacturing and distribution of pharmaceutical products, health food drinks and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 004310 is 3,655 KRW — it has increased by 1.11% in the past 24 hours. Watch HYUNDAI PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HYUNDAI PHARM stocks are traded under the ticker 004310.
004310 stock has risen by 7.03% compared to the previous week, the month change is a −13.59% fall, over the last year HYUNDAI PHARM has showed a −8.63% decrease.
004310 reached its all-time high on Dec 23, 2020 with the price of 11,000 KRW, and its all-time low was 950 KRW and was reached on Jan 12, 2004. View more price dynamics on 004310 chart.
See other stocks reaching their highest and lowest prices.
004310 stock is 4.25% volatile and has beta coefficient of −0.17. Track HYUNDAI PHARM stock price on the chart and check out the list of the most volatile stocks — is HYUNDAI PHARM there?
Today HYUNDAI PHARM has the market capitalization of ‪94.48 B‬, it has increased by 4.93% over the last week.
Yes, you can track HYUNDAI PHARM financials in yearly and quarterly reports right on TradingView.
004310 net income for the last quarter is ‪−487.44 M‬ KRW, while the quarter before that showed ‪1.08 B‬ KRW of net income which accounts for −145.06% change. Track more HYUNDAI PHARM financial stats to get the full picture.
Yes, 004310 dividends are paid annually. The last dividend per share was 35.00 KRW. As of today, Dividend Yield (TTM)% is 0.97%. Tracking HYUNDAI PHARM dividends might help you take more informed decisions.
As of Nov 21, 2024, the company has 385.00 employees. See our rating of the largest employees — is HYUNDAI PHARM on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HYUNDAI PHARM EBITDA is ‪4.47 B‬ KRW, and current EBITDA margin is 5.66%. See more stats in HYUNDAI PHARM financial statements.
Like other stocks, 004310 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HYUNDAI PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HYUNDAI PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HYUNDAI PHARM stock shows the sell signal. See more of HYUNDAI PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.